The Danish Lymphoid Cancer Research (DALY-CARE): Genetic Cohort Profile

Area of Science:

• Hematology
• Genetics
• Cancer Research

Background:

• Lymphoid cancers (LCs) represent a significant health burden.
• Understanding the genetic factors influencing LC progression and treatment is crucial for improving patient outcomes.
• The Danish Lymphoid Cancer Research (DALY-CARE) Genetic Cohort was established to address these knowledge gaps.

Purpose of the Study:

• To establish a comprehensive genetic cohort for lymphoid cancer research.
• To investigate the influence of genetic factors on LC disease progression, treatment response, toxicity, and survival.
• To provide a platform for genetic epidemiology and future multi-omics research in LCs.

Main Methods:

• The DALY-CARE Genetic Cohort comprises 8675 genotyped individuals from a larger population (n=74,251).
• Genetic data are integrated with clinical information from national health registers, electronic health records (EHR), laboratory data, and pathology reports.
• Kinship and ancestry analyses were performed to characterize the cohort's genetic relatedness and demographic background.

Main Results:

• Hematologic malignancy, infections, and other cancers were the leading causes of death.
• Comorbidities such as hypertension and cardiovascular disease were prevalent.
• The cohort consists predominantly of individuals of Northwestern European descent with limited relatedness.

Conclusions:

• The DALY-CARE Genetic Cohort is a valuable resource for studying genetic and clinical determinants of LC outcomes.
• Integration of genotype data with EHR and national health registers facilitates research into germline risk and protective variants.
• Future integration of multi-omics data will position the cohort as a national platform for advanced LC research.